睿智医药: directors' dealings · France · AMF

Explore the full insider trade history of 睿智医药, a listed issuer based in France. Shares trade on FR FR, under the supervision of AMF. Market capitalisation: €4.8bn. The latest transaction was reported on 9 August 2021 (Purchase). Among the most active insiders: 齐家辉. All data is accessible without an account.